Synthetic Control Arm

RWE Methods · Synthetic Controls

Synthetic Control Arms

14 to 15 October 2026Hampton Inn by Hilton, Boston Seaport, USA

A synthetic control arm builds a comparator from patient-level real-world data, statistically matched to the treated group so a single-arm trial reads as if it were controlled.

Synthetic controls, and the matching methods behind them, are on the agenda at RWE Connect 2026 in Boston.

Get the RWE Study Methods Primer
A plain-English guide to the core methods. Instant download, three fields.










    Free. Instant download. No obligation.

    150+Attendees
    60%Director / VP and Above
    40+Speakers
    200+Meetings Facilitated

    What defines it

    What Makes a Control “Synthetic”

    A synthetic control is more than a comparison group pulled from other data. It is engineered, patient by patient, to resemble the treated arm.

    Patient-Level Data
    Built from individual records, not aggregate summaries.
    Statistical Matching
    Patients matched or weighted to the treated group.
    Balanced Covariates
    Key characteristics balanced across the two groups.
    One-to-One or Weighted
    Matched pairs or a reweighted comparator group.
    Emulates Randomization
    Approximates the balance a randomized arm would give.
    Fit-for-Purpose Data
    Real-world data rich enough to match the trial.

    The refinement

    Historical vs Synthetic Control

    A synthetic control is a more rigorous cousin of the historical control. Both look outside the trial; only one is matched at the patient level.

    Historical Control

    • Uses a whole prior cohort
    • Often unadjusted for differences
    • Coarse, group-level comparison
    • Simple to assemble

    Synthetic Control

    • Matched at the patient level
    • Covariates balanced by design
    • Emulates a randomized arm
    • Method-intensive and rigorous

    A synthetic control is a type of external control arm. See also comparative effectiveness research.

    How it works

    How a Synthetic Control Arm Is Built

    Building a synthetic control is a disciplined sequence, from the trial it emulates to the matched comparison.

    Step 1
    Define the Target TrialThe randomized comparison to emulate.
    Step 2
    Assemble Patient-Level DataFit-for-purpose real-world records.
    Step 3
    Select Matching VariablesThe covariates that drive outcomes.
    Step 4
    Apply Matching or WeightingPropensity scores, IPW or MAIC.
    Step 5
    Check Covariate BalanceConfirm the groups are comparable.
    Step 6
    Compare OutcomesEstimate effects with sensitivity checks.

    The statistical toolkit

    Matching Methods

    The credibility of a synthetic control rests on how patients are matched or weighted. These are the core techniques, and topics of debate at RWE Connect 2026.

    Propensity Score Matching
    Match patients on their probability of treatment.
    Inverse Probability Weighting
    Weight patients to balance the comparison.
    MAIC
    Reweight patient data to match an aggregate comparator.
    Exact & Nearest-Neighbor
    Pair patients on closely matching characteristics.
    Standardization
    Adjust outcomes to a common reference population.
    Covariate Balancing
    Optimize weights to equalize measured factors.

    Getting it right

    Keeping Synthetic Controls Credible

    Matching is only convincing when the assumptions behind it are tested and reported. These are the essentials.

    Pre-Specified Estimand
    Define the target effect before analysis.
    Sufficient Overlap
    Enough comparable patients to match on.
    Balance Diagnostics
    Confirm covariates are balanced after matching.
    Unmeasured Confounding
    Assess factors the data cannot capture.
    Sensitivity Analysis
    Test how robust the result is to assumptions.
    Transparency
    Report data, methods and matching in full.

    The direction of travel

    Where Synthetic Controls Are Heading in 2026

    Synthetic comparators are moving into the mainstream of evidence generation. These are the shifts on the agenda at RWE Connect 2026.

    Growing Regulatory Acceptance
    FDA and EMA guidance on synthetic comparators evolving.
    Oncology & Rare Disease
    The leading fields for synthetic control arms.
    Tokenized & Linked Data
    Richer patient-level data to match against.
    Target Trial Emulation
    Framing the synthetic comparison rigorously.
    AI-Assisted Matching
    Machine learning refining covariate balance.
    Standardized Reporting
    Pre-specification and reproducible methods.

    Who is in the room

    Who Attends RWE Connect 2026

    A senior, focused audience of the people who design comparators and defend the methods behind them.

    60%Director / VP and Above
    Director / VP and AboveOther senior roles
    Epidemiology & Biostatistics24%
    RWE & Real-World Data22%
    Clinical, Medical & Regulatory18%
    Data Science & Analytics16%
    HEOR & Market Access12%
    Research, Academia & Startups8%

    Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.

    Sponsor RWE Connect 2026

    Meet the Evidence and Methods Buyers in Boston

    The teams that build comparators and defend the methods gather at RWE Connect 2026: 150+ attendees, around 60% at Director or VP level and above.

    Reach the BuyersBiostatistics, epidemiology, RWE and clinical development leaders who build comparators.
    Pre-Scheduled 1:1 MeetingsName the buyers you want; the Partnering Lounge books the meetings before the doors open.
    Demos and SpeakingShow your data, matching methods and case studies to the teams who use them.

    RWE Connect 2026

    Get the RWE Study Methods Primer

    A plain-English guide to the core real-world evidence methods, including synthetic control arms. See the methods, then meet the people applying them in Boston.

    • How synthetic controls are constructed
    • The matching methods that make them credible
    • Where the methods are heading in 2026

    Interested in sponsoring? See sponsorship options

    Get the RWE Study Methods Primer
    Instant download. Three fields.










      Free. Instant download. No obligation.

      Synthetic Control Arms: Common Questions

      What is a synthetic control arm?

      A synthetic control arm is a comparator built from patient-level real-world data that is statistically matched or weighted to resemble the treated group, so a single-arm trial can be interpreted as if it had a randomized control.

      What is the difference between a synthetic and an external control arm?

      A synthetic control arm is a specific type of external control. An external control is any comparator drawn from outside the trial, while a synthetic control is built at the patient level using matching or weighting to balance covariates with the treated group.

      What is the difference between a synthetic and a historical control?

      A historical control uses a whole prior cohort, often unadjusted. A synthetic control matches or weights patients at the individual level to balance measured characteristics with the treated group.

      How is a synthetic control arm built?

      By defining the target trial, assembling patient-level real-world data, selecting matching variables, applying matching or weighting such as propensity scores or MAIC, checking covariate balance, and comparing outcomes.

      What is MAIC?

      Matching-adjusted indirect comparison (MAIC) reweights patient-level data from one study so its characteristics match an aggregate comparator, a common technique for building synthetic comparators.

      What matching methods are used?

      Propensity score matching, inverse probability weighting, MAIC, exact and nearest-neighbor matching, standardization, and covariate-balancing approaches.

      Are synthetic control arms accepted by regulators?

      In appropriate settings, yes, within FDA and EMA frameworks, when the data and matching methods are fit for the question. They are most established in oncology and rare disease.

      What data is used to build a synthetic control arm?

      Patient-level real-world data such as electronic health records, registries, natural history studies and patient-level data from prior trials, with enough overlap to match the treated group.

      How do you validate a synthetic control arm?

      By pre-specifying the estimand, checking covariate balance and overlap, running sensitivity analyses for unmeasured confounding, and reporting the methods transparently.

      When should a synthetic control arm be used?

      When a randomized control is not feasible or ethical, such as in rare diseases or single-arm trials, and rich patient-level data exists to build a balanced comparator.

      What is RWE Connect 2026?

      RWE Connect 2026 is a two-day real-world evidence summit in Boston bringing together the RWE, HEOR and methods leaders who generate and apply real-world evidence, with 40+ speakers and 150+ attendees.

      When and where is RWE Connect 2026?

      14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.

      Join the Movement. Shape the Future.

      Be part of a community that’s redefining how the world measures healthcare impact.

      Join us at RWE Connect 2026
      where data meets decisions.

      Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆